See also this year's filing and all EDGAR filings for this company.
PDF Report 0001645469_2022_Monopar_Therapeutics.pdf
Logs
Graph
Absolute values for 0001645469, Monopar Therapeutics
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 20,521,614 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,580,543 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,788,750 |
| 9 | ResearchAndDevelopmentExpense | 18,587,240 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 119,495 |
| 12 | remainder_NetIncome | -59,911 |
| 13 | remainder_ComprehensiveNetIncome | 4,429 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 20,521,614 |
| 1 | Liabilities | 1,580,543 |
| 2 | Expenses | 21,375,990 |
| 3 | Revenues | 119,495 |
| 4 | StockholdersEquity | 18,941,071 |
| 5 | NetIncome | -21,316,406 |
| 6 | ComprehensiveNetIncome | -21,314,192 |
| 7 | BaseVar | 21,830,991 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.81 |
| 9 | EconomicCapitalRatio | 2.89 |
Edgar->Model Mapping
Feature Distribution
Change over Time
